News
As healthcare organizations navigate large-scale EHR transitions in 2025, patient access is gaining renewed attention, not ...
The Drug Allergy History Tool, which relies on patient symptom reporting, has strong reliability when compared with EHR drug allergy information.
2d
Santa Cruz Sentinel on MSNSanta Cruz | Innovative heart failure surgery performed at Dominican HospitalSurgeons at Dignity Health Dominican Hospital in Santa Cruz have successfully performed a cutting-edge heart treatment ...
SALT LAKE CITY (KTVX) — When she first got her cancer diagnosis years ago ... the treatment room as Dukhi awaited the end of ...
This guidance is part of the The purpose of health records section of the Good practice guidelines for GP electronic patient records ... by variety of attributes such as episode descriptors (First ...
First Patient Treated with HG-CT-1 CAR-T Therapy Passes Initial Safety Tests Hemogenyx Pharmaceuticals plc is pleased to announce that the first patient has been successfully treated as part of ...
The hospital used an advanced therapy called Lyfgenia, which modifies a patient's own bone marrow ... groundbreaking genetic treatment, he is the first person in New York to be cured of the ...
The GalaFlex Lite scaffold. [Image courtesy of BD] BD (NYSE: BDX) + announced today that investigators treated the first patient in a study of its GalaFlex Lite scaffold system. The FDA ...
Doctors at Northwell Health in New York used stem cell therapy Lyfgenia to cure sickle cell anemia for the first time. HealthDay News — For ... which modifies a patient’s own bone marrow to produce ...
Now that data is being linked with electronic medical records and analysed in an effort to predict medical problems and direct nurses' care – sometimes before they've evaluated the patient ...
The first patient has been dosed in a phase 2b trial evaluating the first-in-class agent Halneuron for those with neuropathic pain following chemotherapy. The first patient has been dosed in the phase ...
1 Recent data from newly diagnosed patients show that about 10% of those starting a novel therapy had an early relapse (within 12 months), while 28% had their first relapse within ... For example, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results